Out now: New issue of our customer magazine bioLOGICAL

197

We are very pleased to present the fourth edition of our customer magazine bioLOGICAL. Enjoy the exciting contents and gain some insights into the subjects that have kept us busy in 2020.

bioLOGICAL. Being strong together 

This issue deals with the topics that have been of special relevance to us in 2020: the new coronavirus (Sars-CoV-2) and sustainability in the field of medical technology and life science.

We provide you with an insight into the antibody test procedure of SARS-CoV-2 and indicate the stages of this where Greiner Bio-One products can also play a decisive role. We have also been able to launch an important new product during the crisis: The virus stabilization tube. We inter- view Moritz Wiesbauer, Team Leader Physical Testing and Change Control at Greiner Bio-One, who answers questions on development and what the company can learn from the crisis.

Find out why plastic is indispensable in medical technology and what advantages it has for the industry compared with other materials, for example. Blue Plan is Greiner AG‘s sustainability strategy, which also gives rise to measures for Greiner Bio-One. Stefan Grafenhorst, Head of Sustainability and Corporate Responsibility, Greiner AG, answers five interesting questions about sustainability and the Blue Plan.

Company: Greiner Bio-One International GmbH


Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, Bio-Science and Sterilization. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors.

In 2019, Greiner Bio-One International GmbH generated a turnover of 509 million euros and had 2,320 employees,28 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG,which is based in Kremsmünster (Austria)

Send Enquiry for this story

By submitting this form you are giving a consent to HHMGlobal.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.